ArticleCancer immunology, immunotherapy : CII2021
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells.
Christiane Braun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it